Anthony Patterson got lucky — twice. His first stroke of good fortune came in 2011, when a fall led him to the emergency room of a local hospital. While he was there, doctors noticed his heart wasn’t ...

About a decade later, the U.S. Preventive Services Taskforce (USPSTF) issued updated guidelines recommending annual screening for lung cancer with low-dose CT for adults ages 50 to 80 years with a 20 ...

BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced that WPS Government Health Administrators, ...

LOUISVILLE, Colo., May 15, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (BDSX) (Nasdaq: BDSX), a leading diagnostic solutions company, announced that new data will be presented at the International Society ...

Diagnosing lung diseases is easier than it used to be with a new state-of-the-art pulmonary function machine recently installed at St. Luke's Hospital. A Vmax Series product from Sensor Medics is a ...

Biodesix, Inc. announced a new study published in CHEST Pulmonary Journal reaffirming the effectiveness of its Nodify CDT® blood-based lung nodule test, which assesses seven autoantibodies linked to ...

One of the largest studies to investigate whether Preserved Ratio Impaired Spirometry (PRISm), an understudied low lung function state, is an early predictor of co-morbidities has found it is strongly ...

Please provide your email address to receive an email when new articles are posted on . Full pulmonary function tests contribute useful diagnostic information for evaluating patients with ...

A new study led by researchers at Johns Hopkins Kimmel Cancer Center is showing a novel blood test can detect the presence of lung cancer with over 90 percent accuracy. The test uses artificial ...

Metabolomx, a diagnostic company focused on the detection of the metabolomics signature of cancer from exhaled breath, today announces publication of results from the first clinical study ...